CYCLOPHOSPHAMIDE INJECTION, SOLUTION

CYCLOPHOSPHAMIDE INJECTION, SOLUTION was reported 179388 times

These side effects are most commonly reported by patients taking CYCLOPHOSPHAMIDE INJECTION, SOLUTION:

# Side effect Count
0 OFF LABEL USE 16826
1 FEBRILE NEUTROPENIA 14786
2 DRUG INEFFECTIVE 10786
3 NEUTROPENIA 10778
4 PYREXIA 9366
5 DISEASE PROGRESSION 8229
6 PNEUMONIA 6777
7 THROMBOCYTOPENIA 6679
8 PRODUCT USE IN UNAPPROVED INDICATION 6563
9 NAUSEA 6352
10 ANAEMIA 6284
11 SEPSIS 5805
12 DIARRHOEA 5568
13 DEATH 5287
14 VOMITING 4999
15 INFECTION 4742
16 MYELOSUPPRESSION 4509
17 PANCYTOPENIA 4429
18 WHITE BLOOD CELL COUNT DECREASED 4298
19 FATIGUE 4284
20 CYTOKINE RELEASE SYNDROME 3893
21 DYSPNOEA 3855
22 MUCOSAL INFLAMMATION 3669
23 NEUROPATHY PERIPHERAL 3553
24 MALIGNANT NEOPLASM PROGRESSION 3228
25 PLATELET COUNT DECREASED 3227
26 ASTHENIA 3190
27 SEPTIC SHOCK 3164
28 LEUKOPENIA 3155
29 NEUTROPHIL COUNT DECREASED 3114
30 RESPIRATORY FAILURE 3102
31 ACUTE KIDNEY INJURY 2843
32 HYPOTENSION 2830
33 PLASMA CELL MYELOMA 2602
34 CONDITION AGGRAVATED 2557
35 COVID-19 2526
36 HEADACHE 2406
37 ACUTE MYELOID LEUKAEMIA 2342
38 MYELODYSPLASTIC SYNDROME 2336
39 CYTOMEGALOVIRUS INFECTION 2335
40 ABDOMINAL PAIN 2286
41 DECREASED APPETITE 2160
42 ALOPECIA 2136
43 BONE MARROW FAILURE 2127
44 CARDIAC FAILURE 2117
45 PAIN 2085
46 COUGH 2081
47 RENAL FAILURE 2064
48 TOXICITY TO VARIOUS AGENTS 2050
49 RASH 2044
50 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1980
51 HAEMOGLOBIN DECREASED 1966
52 PLEURAL EFFUSION 1943
53 INTERSTITIAL LUNG DISEASE 1804
54 HYPERTENSION 1774
55 CONSTIPATION 1751
56 PULMONARY EMBOLISM 1733
57 DIFFUSE LARGE B-CELL LYMPHOMA 1717
58 STOMATITIS 1696
59 THERAPY PARTIAL RESPONDER 1689
60 GENERAL PHYSICAL HEALTH DETERIORATION 1685
61 DISEASE RECURRENCE 1679
62 HAEMATOTOXICITY 1616
63 CYTOPENIA 1613
64 NEOPLASM PROGRESSION 1608
65 INTENTIONAL PRODUCT USE ISSUE 1600
66 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1565
67 PRODUCT USE ISSUE 1539
68 URINARY TRACT INFECTION 1527
69 MALAISE 1520
70 THERAPY NON-RESPONDER 1486
71 HYPOGAMMAGLOBULINAEMIA 1472
72 ATRIAL FIBRILLATION 1469
73 DIZZINESS 1450
74 ACUTE GRAFT VERSUS HOST DISEASE 1437
75 NEUROTOXICITY 1426
76 WEIGHT DECREASED 1426
77 CYTOMEGALOVIRUS INFECTION REACTIVATION 1398
78 CHILLS 1397
79 ALANINE AMINOTRANSFERASE INCREASED 1395
80 ARTHRALGIA 1390
81 TREATMENT FAILURE 1365
82 GRAFT VERSUS HOST DISEASE 1353
83 RENAL IMPAIRMENT 1348
84 LYMPHOPENIA 1336
85 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 1305
86 HYPOKALAEMIA 1301
87 SECOND PRIMARY MALIGNANCY 1297
88 DEHYDRATION 1295
89 VENOOCCLUSIVE LIVER DISEASE 1289
90 TUMOUR LYSIS SYNDROME 1264
91 DEEP VEIN THROMBOSIS 1257
92 CARDIOTOXICITY 1248
93 GASTROINTESTINAL DISORDER 1247
94 BACK PAIN 1246
95 AGRANULOCYTOSIS 1240
96 PNEUMOCYSTIS JIROVECII PNEUMONIA 1234
97 TACHYCARDIA 1233
98 LYMPHADENOPATHY 1229
99 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 1229
100 HYPOXIA 1222
101 NEUTROPENIC SEPSIS 1219
102 HERPES ZOSTER 1207
103 HEPATIC FUNCTION ABNORMAL 1196
104 CYSTITIS HAEMORRHAGIC 1160
105 PNEUMONITIS 1145
106 ASPARTATE AMINOTRANSFERASE INCREASED 1140
107 DRUG INTOLERANCE 1116
108 BLOOD LACTATE DEHYDROGENASE INCREASED 1106
109 CONFUSIONAL STATE 1102
110 CHEST PAIN 1093
111 HYPONATRAEMIA 1083
112 SEIZURE 1074
113 BRONCHOPULMONARY ASPERGILLOSIS 1071
114 CHRONIC GRAFT VERSUS HOST DISEASE 1057
115 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1034
116 BACTERIAL INFECTION 1030
117 LYMPHOCYTE COUNT DECREASED 1027
118 OEDEMA PERIPHERAL 1027
119 DRUG INTERACTION 1022
120 STAPHYLOCOCCAL INFECTION 1005
121 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 997
122 BACTERAEMIA 990
123 PAIN IN EXTREMITY 985
124 EJECTION FRACTION DECREASED 976
125 THROMBOTIC MICROANGIOPATHY 976
126 GASTROINTESTINAL HAEMORRHAGE 967
127 HEPATIC FAILURE 963
128 FUNGAL INFECTION 960
129 HEPATOTOXICITY 959
130 BONE PAIN 943
131 BLOOD CREATININE INCREASED 941
132 C-REACTIVE PROTEIN INCREASED 940
133 COLITIS 938
134 DYSPHAGIA 937
135 ASCITES 935
136 MYALGIA 932
137 INFUSION RELATED REACTION 925
138 CLOSTRIDIUM DIFFICILE COLITIS 907
139 SYNCOPE 900
140 DRUG RESISTANCE 896
141 PARAESTHESIA 895
142 MUSCULAR WEAKNESS 894
143 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 893
144 FEBRILE BONE MARROW APLASIA 887
145 ACUTE RESPIRATORY DISTRESS SYNDROME 880
146 HEPATITIS B 877
147 CARDIOMYOPATHY 875
148 EPSTEIN-BARR VIRUS INFECTION 875
149 CELLULITIS 869
150 HYPERSENSITIVITY 863
151 CARDIAC ARREST 848
152 BK VIRUS INFECTION 840
153 ASPERGILLUS INFECTION 837
154 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 836
155 ERYTHEMA 830
156 ENCEPHALOPATHY 825
157 FALL 817
158 POLYNEUROPATHY 808
159 PRURITUS 805
160 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 801
161 HEPATITIS B REACTIVATION 797
162 RESPIRATORY DISTRESS 797
163 CYTOMEGALOVIRUS VIRAEMIA 778
164 LYMPHOMA 778
165 HYPOAESTHESIA 775
166 HYPERGLYCAEMIA 752
167 PERICARDIAL EFFUSION 747
168 BLOOD BILIRUBIN INCREASED 744
169 CANDIDA INFECTION 744
170 HAEMATURIA 744
171 MATERNAL EXPOSURE DURING PREGNANCY 740
172 LUNG DISORDER 735
173 CARDIAC FAILURE CONGESTIVE 734
174 VENOOCCLUSIVE DISEASE 714
175 OEDEMA 705
176 OSTEONECROSIS 702
177 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 699
178 ANXIETY 697
179 HAEMORRHAGE 697
180 PULMONARY OEDEMA 688
181 MULTI-ORGAN FAILURE 680
182 ABDOMINAL PAIN UPPER 678
183 PSEUDOMONAS INFECTION 675
184 FOETAL EXPOSURE DURING PREGNANCY 667
185 UPPER RESPIRATORY TRACT INFECTION 666
186 THERAPEUTIC RESPONSE DECREASED 660
187 INSOMNIA 659
188 RESPIRATORY TRACT INFECTION 656
189 NEPHROPATHY TOXIC 655
190 TRANSAMINASES INCREASED 655
191 TREMOR 654
192 EPISTAXIS 650
193 THROMBOSIS 639
194 METASTASES TO BONE 638
195 VIRAL INFECTION 631
196 DRUG-INDUCED LIVER INJURY 629
197 ADENOVIRUS INFECTION 622
198 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 619
199 PERIPHERAL SENSORY NEUROPATHY 595
200 WEIGHT INCREASED 595
201 COVID-19 PNEUMONIA 592
202 CHEST DISCOMFORT 589
203 CLOSTRIDIUM DIFFICILE INFECTION 585
204 INFLUENZA 584
205 SINUSITIS 582
206 DRUG HYPERSENSITIVITY 579
207 LEFT VENTRICULAR DYSFUNCTION 577
208 LOWER RESPIRATORY TRACT INFECTION 569
209 PREMATURE BABY 567
210 KLEBSIELLA INFECTION 561
211 DEPRESSION 559
212 DEVICE RELATED INFECTION 556
213 DISSEMINATED INTRAVASCULAR COAGULATION 554
214 METASTASES TO LIVER 554
215 LIVER DISORDER 552
216 CEREBROVASCULAR ACCIDENT 551
217 NERVOUS SYSTEM DISORDER 551
218 GRAFT VERSUS HOST DISEASE IN SKIN 547
219 ABDOMINAL DISTENSION 539
220 ENTEROCOCCAL INFECTION 533
221 MYOCARDIAL INFARCTION 533
222 OROPHARYNGEAL PAIN 531
223 HAEMATOCRIT DECREASED 526
224 LOSS OF CONSCIOUSNESS 522
225 RENAL FAILURE ACUTE 521
226 SOMNOLENCE 521
227 HYPERBILIRUBINAEMIA 514
228 CARDIAC DISORDER 512
229 HERPES SIMPLEX 508
230 GAIT DISTURBANCE 507
231 ARRHYTHMIA 505
232 HEPATIC ENZYME INCREASED 502
233 LUNG INFECTION 502
234 LUNG INFILTRATION 495
235 BREAST CANCER 494
236 LIVER INJURY 494
237 ACUTE HEPATIC FAILURE 493
238 WHITE BLOOD CELL COUNT INCREASED 488
239 ACUTE RESPIRATORY FAILURE 486
240 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 485
241 HUMAN HERPESVIRUS 6 INFECTION 481
242 HYPOCALCAEMIA 478
243 PROTEINURIA 476
244 PANCREATITIS 471
245 HEPATITIS 470
246 HYPOALBUMINAEMIA 467
247 STAPHYLOCOCCAL BACTERAEMIA 458
248 STAPHYLOCOCCAL SEPSIS 456
249 PNEUMONIA FUNGAL 453
250 ESCHERICHIA INFECTION 449
251 OXYGEN SATURATION DECREASED 446
252 APHASIA 442
253 HYPOTHYROIDISM 441
254 ILL-DEFINED DISORDER 441
255 BREAST CANCER METASTATIC 440
256 PRODUCTIVE COUGH 440
257 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 439
258 CEREBRAL HAEMORRHAGE 437
259 CYTOMEGALOVIRUS CHORIORETINITIS 433
260 METASTASES TO LUNG 431
261 GAMMA-GLUTAMYLTRANSFERASE INCREASED 430
262 DEPRESSED LEVEL OF CONSCIOUSNESS 426
263 APLASTIC ANAEMIA 424
264 BRADYCARDIA 424
265 DIABETES MELLITUS 424
266 COGNITIVE DISORDER 423
267 SPLENOMEGALY 423
268 INFLAMMATION 422
269 NEOPLASM MALIGNANT 421
270 PSYCHOLOGICAL TRAUMA 421
271 MENTAL STATUS CHANGES 419
272 PNEUMONIA BACTERIAL 418
273 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 408
274 COAGULOPATHY 406
275 ABDOMINAL DISCOMFORT 404
276 METASTASES TO CENTRAL NERVOUS SYSTEM 404
277 ANAPHYLACTIC REACTION 396
278 LEUKOCYTOSIS 396
279 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 395
280 BACTERIAL SEPSIS 394
281 CONVULSION 394
282 HYPERHIDROSIS 394
283 NO ADVERSE EVENT 392
284 PULMONARY TOXICITY 391
285 MUSCLE SPASMS 388
286 SKIN LESION 388
287 DYSPNOEA EXERTIONAL 386
288 PALPITATIONS 385
289 PULMONARY HAEMORRHAGE 382
290 PULMONARY HYPERTENSION 382
291 GASTROINTESTINAL TOXICITY 381
292 HYPERKALAEMIA 378
293 INTESTINAL PERFORATION 378
294 PULMONARY FIBROSIS 377
295 SINUS TACHYCARDIA 375
296 NASOPHARYNGITIS 372
297 GENERALISED OEDEMA 371
298 HEART RATE INCREASED 370
299 TRANSPLANT FAILURE 369
300 BLOOD ALKALINE PHOSPHATASE INCREASED 367
301 ADVERSE EVENT 366
302 LETHARGY 365
303 VISION BLURRED 365
304 BLOOD PRESSURE DECREASED 363
305 HAIR COLOUR CHANGES 362
306 PNEUMOCYSTIS JIROVECI PNEUMONIA 362
307 ENCEPHALITIS 361
308 HYPOPHAGIA 361
309 METASTASIS 359
310 RESPIRATORY DISORDER 359
311 HAIR TEXTURE ABNORMAL 358
312 MOUTH ULCERATION 358
313 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 357
314 EXPOSURE DURING PREGNANCY 355
315 RHINOVIRUS INFECTION 354
316 ATELECTASIS 353
317 ACUTE LYMPHOCYTIC LEUKAEMIA 351
318 DYSPEPSIA 351
319 MADAROSIS 351
320 OSTEONECROSIS OF JAW 351
321 CHOLESTASIS 349
322 BRONCHITIS 346
323 BLOOD PRESSURE INCREASED 345
324 PNEUMOTHORAX 345
325 NEUTROPENIC COLITIS 344
326 PERIPHERAL SWELLING 344
327 SHOCK 341
328 ORAL CANDIDIASIS 340
329 PANCREATITIS ACUTE 340
330 BLINDNESS 338
331 CHRONIC KIDNEY DISEASE 338
332 OSTEOPOROSIS 338
333 PSEUDOMONAL SEPSIS 338
334 STEM CELL TRANSPLANT 338
335 URTICARIA 337
336 CARDIO-RESPIRATORY ARREST 336
337 MYOCARDITIS 336
338 RHINORRHOEA 336
339 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 335
340 PLASMA CELL MYELOMA RECURRENT 335
341 DELIRIUM 334
342 EMBOLISM 334
343 MEMORY IMPAIRMENT 333
344 PNEUMONIA CYTOMEGALOVIRAL 331
345 RED BLOOD CELL COUNT DECREASED 331
346 VISUAL IMPAIRMENT 331
347 COMA 330
348 CYSTITIS 330
349 DYSARTHRIA 330
350 PULMONARY ALVEOLAR HAEMORRHAGE 329
351 SKIN TOXICITY 329
352 HAEMORRHAGE INTRACRANIAL 328
353 TACHYPNOEA 327
354 ASTHMA 324
355 ACUTE MYOCARDIAL INFARCTION 323
356 ADRENAL INSUFFICIENCY 323
357 SYSTEMIC CANDIDA 323
358 B-CELL LYMPHOMA 322
359 ILEUS 322
360 IMMUNOSUPPRESSION 321
361 CEREBRAL INFARCTION 320
362 ESCHERICHIA SEPSIS 320
363 BODY TEMPERATURE INCREASED 319
364 HEMIPARESIS 319
365 METASTASES TO LYMPH NODES 318
366 DRUG EXPOSURE DURING PREGNANCY 317
367 NEOPLASM RECURRENCE 317
368 END STAGE RENAL DISEASE 315
369 VASCULITIS 310
370 NON-HODGKIN^S LYMPHOMA 309
371 EMOTIONAL DISTRESS 308
372 BASAL CELL CARCINOMA 307
373 CATARACT 305
374 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 305
375 JAUNDICE 305
376 RASH MACULO-PAPULAR 305
377 SECONDARY IMMUNODEFICIENCY 303
378 ELECTROCARDIOGRAM QT PROLONGED 302
379 ELECTROLYTE IMBALANCE 302
380 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 302
381 LEUKOENCEPHALOPATHY 300
382 HAIR DISORDER 299
383 BRAIN OEDEMA 298
384 MUCORMYCOSIS 298
385 RENAL DISORDER 298
386 HAEMOPTYSIS 297
387 ORGANISING PNEUMONIA 297
388 EPILEPSY 296
389 NEOPLASM 295
390 PLASMA CELL MYELOMA REFRACTORY 294
391 VIRAL HAEMORRHAGIC CYSTITIS 294
392 HISTIOCYTOSIS HAEMATOPHAGIC 292
393 HYPERCALCAEMIA 292
394 HYPOMAGNESAEMIA 292
395 JC VIRUS INFECTION 292
396 HEPATIC STEATOSIS 289
397 HEPATOMEGALY 289
398 SKIN EXFOLIATION 289
399 DYSURIA 284
400 APLASIA 283
401 CHRONIC LYMPHOCYTIC LEUKAEMIA 283
402 HYPERTRANSAMINASAEMIA 283
403 CARDIOGENIC SHOCK 282
404 PARAINFLUENZAE VIRUS INFECTION 282
405 PNEUMONIA ASPIRATION 282
406 HYPOPHOSPHATAEMIA 281
407 DRUG TOXICITY 280
408 RESPIRATORY SYNCYTIAL VIRUS INFECTION 278
409 VARICELLA ZOSTER VIRUS INFECTION 277
410 HEPATIC CYTOLYSIS 275
411 ORAL HERPES 275
412 SKIN INFECTION 275
413 PULMONARY MASS 274
414 ESCHERICHIA BACTERAEMIA 272
415 METABOLIC ACIDOSIS 272
416 TOXIC EPIDERMAL NECROLYSIS 272
417 ENTERITIS 271
418 MALNUTRITION 271
419 OESOPHAGITIS 269
420 GASTROOESOPHAGEAL REFLUX DISEASE 268
421 AGITATION 265
422 FOLLICULAR LYMPHOMA 265
423 BLOOD GLUCOSE INCREASED 263
424 HYPERTRIGLYCERIDAEMIA 263
425 NIGHT SWEATS 263
426 FEELING ABNORMAL 262
427 CENTRAL NERVOUS SYSTEM LYMPHOMA 261
428 DISCOMFORT 261
429 DISORIENTATION 261
430 PNEUMATOSIS INTESTINALIS 261
431 WHEEZING 261
432 DEAFNESS 259
433 HODGKIN^S DISEASE 259
434 MITRAL VALVE INCOMPETENCE 258
435 PREMATURE DELIVERY 258
436 HOSPITALISATION 257
437 SKIN ULCER 256
438 LIVER FUNCTION TEST ABNORMAL 255
439 HAEMATOCHEZIA 253
440 ORAL PAIN 253
441 VENOUS THROMBOSIS 253
442 AUTOIMMUNE HAEMOLYTIC ANAEMIA 252
443 NEPHROTIC SYNDROME 252
444 RASH ERYTHEMATOUS 251
445 OESOPHAGEAL CANDIDIASIS 250
446 OVERDOSE 250
447 CARDIAC DYSFUNCTION 249
448 SQUAMOUS CELL CARCINOMA OF SKIN 249
449 INTESTINAL OBSTRUCTION 248
450 GASTROENTERITIS 247
451 PULMONARY ARTERIAL HYPERTENSION 247
452 LYMPHOPROLIFERATIVE DISORDER 246
453 GRANULOCYTOPENIA 245
454 MUSCULOSKELETAL PAIN 245
455 EPSTEIN-BARR VIRAEMIA 244
456 RECTAL HAEMORRHAGE 244
457 SWELLING 244
458 SQUAMOUS CELL CARCINOMA 243
459 DYSGEUSIA 242
460 PERITONITIS 242
461 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 240
462 CIRCULATORY COLLAPSE 239
463 SKIN DISORDER 239
464 TUBULOINTERSTITIAL NEPHRITIS 239
465 UROSEPSIS 239
466 SMALL INTESTINAL OBSTRUCTION 238
467 ALTERED STATE OF CONSCIOUSNESS 237
468 ENGRAFTMENT SYNDROME 237
469 JOINT SWELLING 237
470 BLOOD CULTURE POSITIVE 236
471 SUBDURAL HAEMATOMA 236
472 GENERALISED TONIC-CLONIC SEIZURE 235
473 IMMUNODEFICIENCY 235
474 GASTRITIS 232
475 HAEMATEMESIS 232
476 B-CELL LYMPHOMA RECURRENT 230
477 HAEMOLYTIC ANAEMIA 230
478 PROSTATE CANCER 230
479 ENTEROBACTER INFECTION 229
480 FULL BLOOD COUNT DECREASED 229
481 URINARY RETENTION 229
482 GRANULOCYTE COUNT DECREASED 228
483 PERICARDITIS 228
484 CARDIAC FAILURE ACUTE 227
485 OSTEOMYELITIS 227
486 RICHTER^S SYNDROME 227
487 UPPER GASTROINTESTINAL HAEMORRHAGE 227
488 LUNG NEOPLASM MALIGNANT 226
489 TRANSPLANT REJECTION 223
490 VENTRICULAR HYPOKINESIA 223
491 ACUTE MYELOID LEUKAEMIA RECURRENT 222
492 LUPUS NEPHRITIS 222
493 CHOLECYSTITIS 221
494 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 221
495 MASS 221
496 FLUSHING 220
497 BREAST CANCER RECURRENT 219
498 NEUTROPHIL COUNT INCREASED 219
499 SPEECH DISORDER 219
500 SYSTEMIC MYCOSIS 219
501 LEUKAEMIA RECURRENT 218
502 MYOSITIS 218
503 HAEMATOMA 217
504 INFLUENZA LIKE ILLNESS 217
505 ATAXIA 216
506 DISTURBANCE IN ATTENTION 215
507 ENTEROCOLITIS 215
508 HEPATOCELLULAR INJURY 215
509 BRAIN ABSCESS 212
510 BLISTER 211
511 FOETAL GROWTH RESTRICTION 211
512 CONGESTIVE CARDIOMYOPATHY 210
513 PATHOGEN RESISTANCE 209
514 SWELLING FACE 209
515 CAPILLARY LEAK SYNDROME 208
516 DIVERTICULITIS 208
517 PALLOR 208
518 HYDRONEPHROSIS 206
519 PLASMACYTOMA 206
520 NECK PAIN 205
521 BLOOD POTASSIUM DECREASED 204
522 MUSCULOSKELETAL STIFFNESS 204
523 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 204
524 ADVERSE DRUG REACTION 203
525 UNEVALUABLE EVENT 203
526 ACUTE PULMONARY OEDEMA 202
527 FLUID RETENTION 202
528 IMPAIRED QUALITY OF LIFE 201
529 NOCARDIOSIS 201
530 SLEEP DISORDER 201
531 VIRAEMIA 201
532 BONE MARROW DISORDER 200
533 ISCHAEMIC STROKE 199
534 PYELONEPHRITIS 199
535 ABSCESS 198
536 DIPLOPIA 198
537 MELAENA 198
538 CYTOMEGALOVIRUS COLITIS 197
539 HAEMODYNAMIC INSTABILITY 197
540 HAEMORRHOIDS 196
541 ILEUS PARALYTIC 195
542 CYTOMEGALOVIRUS TEST POSITIVE 194
543 NEUTROPENIC INFECTION 193
544 RHEUMATOID ARTHRITIS 193
545 SYSTEMIC LUPUS ERYTHEMATOSUS 193
546 WHITE BLOOD CELL COUNT ABNORMAL 193
547 BALANCE DISORDER 191
548 MANTLE CELL LYMPHOMA RECURRENT 191
549 SERUM FERRITIN INCREASED 191
550 ACUTE PROMYELOCYTIC LEUKAEMIA 190
551 GASTRIC ULCER 189
552 GUILLAIN-BARRE SYNDROME 189
553 KAPOSI^S SARCOMA 188
554 STATUS EPILEPTICUS 188
555 ENTEROCOCCAL BACTERAEMIA 187
556 KLEBSIELLA SEPSIS 187
557 ORTHOSTATIC HYPOTENSION 187
558 HERPES VIRUS INFECTION 186
559 HOT FLUSH 186
560 MALIGNANT MELANOMA 186
561 NEURALGIA 186
562 UNRESPONSIVE TO STIMULI 186
563 LOW BIRTH WEIGHT BABY 185
564 NECROSIS 185
565 PREMATURE MENOPAUSE 185
566 HAEMOLYSIS 184
567 LEUKAEMIA 184
568 VISUAL ACUITY REDUCED 184
569 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 183
570 BLOOD UREA INCREASED 183
571 DRY MOUTH 183
572 MENTAL DISORDER 183
573 NASAL CONGESTION 183
574 ILLNESS 182
575 MYELOPATHY 182
576 TUBERCULOSIS 182
577 ARTHRITIS 181
578 BLOOD SODIUM DECREASED 181
579 CONTUSION 181
580 DYSPHONIA 181
581 GENE MUTATION 181
582 OBESITY 181
583 CYSTITIS VIRAL 180
584 ESCHERICHIA URINARY TRACT INFECTION 180
585 HEPATIC ENCEPHALOPATHY 180
586 ANGINA PECTORIS 179
587 GASTROINTESTINAL INFECTION 179
588 LACTIC ACIDOSIS 179
589 PERIPHERAL MOTOR NEUROPATHY 178
590 POLLAKIURIA 178
591 HYPOGLYCAEMIA 177
592 NO THERAPEUTIC RESPONSE 176
593 PAIN IN JAW 176
594 HYPERPYREXIA 175
595 MANTLE CELL LYMPHOMA 174
596 MENINGITIS 174
597 CARDIOMEGALY 173
598 INFECTION REACTIVATION 173
599 PETECHIAE 173
600 STRONGYLOIDIASIS 173
601 URINARY INCONTINENCE 173
602 BLOOD DISORDER 172
603 CENTRAL NERVOUS SYSTEM LESION 172
604 TROPONIN INCREASED 172
605 LACRIMATION INCREASED 171
606 NEUTROPHIL COUNT ABNORMAL 171
607 RECURRENT CANCER 171
608 B-CELL TYPE ACUTE LEUKAEMIA 170
609 FUNGAEMIA 170
610 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 169
611 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 168
612 TREATMENT NONCOMPLIANCE 168
613 FLUID OVERLOAD 167
614 NON-HODGKIN^S LYMPHOMA RECURRENT 167
615 DRUG ERUPTION 166
616 HAEMOGLOBIN ABNORMAL 166
617 PNEUMONIA VIRAL 166
618 IMMUNE THROMBOCYTOPENIA 165
619 MOBILITY DECREASED 165
620 NODULE 165
621 VENTRICULAR TACHYCARDIA 165
622 DRY SKIN 164
623 HYPERURICAEMIA 164
624 MYOPATHY 164
625 OBLITERATIVE BRONCHIOLITIS 164
626 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 164
627 TINNITUS 163
628 VERTIGO 163
629 DRUG EFFECT INCOMPLETE 162
630 PNEUMOMEDIASTINUM 162
631 SHOCK HAEMORRHAGIC 162
632 DERMATITIS 161
633 ENDOCARDITIS 161
634 HEPATITIS E 161
635 HYPERVOLAEMIA 161
636 GASTROINTESTINAL INFLAMMATION 160
637 LARGE INTESTINE PERFORATION 160
638 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 159
639 APPENDICITIS 159
640 CARDIOVASCULAR DISORDER 159
641 ENCEPHALITIS CYTOMEGALOVIRUS 159
642 LIVER FUNCTION TEST INCREASED 159
643 PNEUMOCYSTIS JIROVECII INFECTION 159
644 PULMONARY CONGESTION 159
645 NEUROLOGICAL SYMPTOM 158
646 SUPRAVENTRICULAR TACHYCARDIA 158
647 SUSPECTED OFF LABEL USE 158
648 TRANSIENT ISCHAEMIC ATTACK 158
649 FACIAL PARALYSIS 157
650 RASH PRURITIC 157
651 RENAL TUBULAR NECROSIS 157
652 SUDDEN DEATH 157
653 ACUTE CORONARY SYNDROME 156
654 LUNG CONSOLIDATION 156
655 MULTIPLE-DRUG RESISTANCE 156
656 STENOTROPHOMONAS INFECTION 156
657 PRODUCT PRESCRIBING ISSUE 155
658 BONE LESION 154
659 HALLUCINATION 154
660 SENSORY DISTURBANCE 154
661 VASCULAR DEVICE INFECTION 154
662 TRICUSPID VALVE INCOMPETENCE 153
663 AMENORRHOEA 152
664 BONE DISORDER 152
665 BRONCHIECTASIS 152
666 PNEUMONIA KLEBSIELLA 152
667 TASTE DISORDER 152
668 ATRIAL FLUTTER 151
669 CEREBRAL TOXOPLASMOSIS 150
670 HYDROCEPHALUS 150
671 IMPAIRED HEALING 150
672 LEFT VENTRICULAR FAILURE 150
673 CONJUNCTIVITIS 149
674 INVASIVE DUCTAL BREAST CARCINOMA 149
675 DIFFUSE ALVEOLAR DAMAGE 148
676 RETINAL HAEMORRHAGE 148
677 STREPTOCOCCAL INFECTION 148
678 TOXOPLASMOSIS 148
679 STEVENS-JOHNSON SYNDROME 147
680 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 146
681 HEPATIC CIRRHOSIS 146
682 MYOCARDIAL ISCHAEMIA 146
683 PATHOLOGICAL FRACTURE 146
684 METASTASES TO MENINGES 145
685 ORAL DISORDER 145
686 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 144
687 CACHEXIA 144
688 CANDIDIASIS 144
689 CHRONIC MYELOID LEUKAEMIA 144
690 HYPOACUSIS 144
691 THYMUS HYPOPLASIA 144
692 GRAFT VERSUS HOST DISEASE IN LIVER 143
693 HEPATITIS C 143
694 LYMPHOID TISSUE HYPOPLASIA 143
695 OSTEOLYSIS 143
696 OVARIAN FAILURE 143
697 CHRONIC SINUSITIS 142
698 HEPATOSPLENOMEGALY 142
699 POLYOMAVIRUS VIRAEMIA 142
700 TRANSFUSION 142
701 CONTRAINDICATED PRODUCT ADMINISTERED 141
702 BLOOD ALBUMIN DECREASED 140
703 EOSINOPHILIA 140
704 HAEMODIALYSIS 140
705 PROCTALGIA 140
706 ANOREXIA 139
707 SOFT TISSUE INFECTION 139
708 OBSTRUCTIVE AIRWAYS DISORDER 138
709 PHARYNGITIS 137
710 PSEUDOMONAL BACTERAEMIA 137
711 ENCEPHALITIS VIRAL 136
712 PRODUCT DOSE OMISSION ISSUE 136
713 PURPURA 136
714 RHABDOMYOLYSIS 136
715 CHOLELITHIASIS 135
716 VENTRICULAR DYSFUNCTION 135
717 ASPERGILLOSIS 134
718 BLOOD IMMUNOGLOBULIN G DECREASED 134
719 CLOSTRIDIAL INFECTION 133
720 CUSHINGOID 133
721 HUMAN POLYOMAVIRUS INFECTION 133
722 MENINGITIS CRYPTOCOCCAL 133
723 GOUT 132
724 ODYNOPHAGIA 132
725 TOXIC SKIN ERUPTION 132
726 ARTHROPATHY 131
727 DEVICE RELATED SEPSIS 131
728 PLATELET COUNT INCREASED 131
729 B-LYMPHOCYTE COUNT DECREASED 130
730 DIASTOLIC DYSFUNCTION 130
731 FEBRILE INFECTION 130
732 MYCOBACTERIUM CHELONAE INFECTION 130
733 APLASIA PURE RED CELL 129
734 ERYSIPELAS 129
735 LABORATORY TEST ABNORMAL 129
736 OLIGURIA 129
737 HEPATIC LESION 128
738 KLEBSIELLA BACTERAEMIA 128
739 PULMONARY TUBERCULOSIS 128
740 BONE MARROW TOXICITY 127
741 DISSEMINATED ASPERGILLOSIS 127
742 METABOLIC DISORDER 127
743 SPINAL FRACTURE 127
744 SUBARACHNOID HAEMORRHAGE 127
745 FUSARIUM INFECTION 126
746 GLOMERULAR FILTRATION RATE DECREASED 126
747 ARTHRITIS BACTERIAL 125
748 STREPTOCOCCAL BACTERAEMIA 125
749 ULCER 125
750 UNDERDOSE 125
751 EOSINOPHIL COUNT INCREASED 124
752 INTRACRANIAL PRESSURE INCREASED 124
753 NAIL DISORDER 124
754 OTOTOXICITY 124
755 CARDIAC TAMPONADE 123
756 INTERNATIONAL NORMALISED RATIO INCREASED 123
757 LYMPHOEDEMA 123
758 THROMBOTIC THROMBOCYTOPENIC PURPURA 123
759 VENTRICULAR EXTRASYSTOLES 123
760 HEPATIC NECROSIS 122
761 JUGULAR VEIN THROMBOSIS 122
762 MULTIPLE MYELOMA 122
763 OLIGOHYDRAMNIOS 122
764 RENAL INJURY 122
765 STRESS CARDIOMYOPATHY 122
766 TENDERNESS 122
767 ANAPHYLACTIC SHOCK 121
768 ANURIA 121
769 CYTOGENETIC ABNORMALITY 121
770 NECROTISING FASCIITIS 121
771 TRANSPLANT DYSFUNCTION 121
772 ACIDOSIS 120
773 DRUG LEVEL INCREASED 120
774 FEEDING DISORDER 120
775 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 120
776 DEPRESSED MOOD 119
777 AMNESIA 118
778 RESPIRATORY SYMPTOM 118
779 SUBCLAVIAN VEIN THROMBOSIS 118
780 HUMAN BOCAVIRUS INFECTION 117
781 MUSCULOSKELETAL CHEST PAIN 117
782 STEROID DIABETES 117
783 CORONAVIRUS INFECTION 116
784 GROWTH RETARDATION 116
785 REBOUND EFFECT 116
786 SPINAL PAIN 116
787 ABDOMINAL ABSCESS 115
788 CHRONIC LYMPHOCYTIC LEUKAEMIA RECURRENT 115
789 HODGKIN^S DISEASE RECURRENT 115
790 OPPORTUNISTIC INFECTION 115
791 VENTRICULAR FIBRILLATION 115
792 NEUROLOGICAL DECOMPENSATION 114
793 PRESYNCOPE 114
794 SKIN DISCOLOURATION 114
795 URINE OUTPUT DECREASED 114
796 AMYLOIDOSIS 113
797 BURNING SENSATION 113
798 DILATED CARDIOMYOPATHY 113
799 EMBOLISM VENOUS 113
800 RED BLOOD CELL SEDIMENTATION RATE INCREASED 113
801 TYPE 2 DIABETES MELLITUS 113
802 CANDIDA SEPSIS 112
803 GASTROINTESTINAL NECROSIS 112
804 GRANULOMATOSIS WITH POLYANGIITIS 112
805 LIPASE INCREASED 112
806 OSTEOARTHRITIS 112
807 RASH PAPULAR 112
808 ACQUIRED GENE MUTATION 111
809 DRY EYE 111
810 FACE OEDEMA 111
811 LUNG NEOPLASM 111
812 PSYCHOTIC DISORDER 111
813 ASPIRATION 110
814 BLOOD CREATINE PHOSPHOKINASE INCREASED 110
815 CARDIAC FAILURE CHRONIC 110
816 EMPYEMA 110
817 ENTEROCOCCAL SEPSIS 110
818 HYPOVOLAEMIA 110
819 LYMPHOCYTOSIS 110
820 PARALYSIS 110
821 PORTAL HYPERTENSION 110
822 RENAL CELL CARCINOMA 110
823 LUNG ADENOCARCINOMA 109
824 PLASMA CELL LEUKAEMIA 109
825 PLATELET COUNT ABNORMAL 109
826 SKIN MASS 109
827 SKIN REACTION 109
828 CYANOSIS 108
829 DECUBITUS ULCER 108
830 HYPERTHYROIDISM 108
831 HYPOFIBRINOGENAEMIA 108
832 HYPOPROTEINAEMIA 108
833 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 108
834 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 108
835 PAPILLOEDEMA 108
836 BLOOD FIBRINOGEN DECREASED 107
837 BURKITT^S LYMPHOMA 107
838 COLON CANCER 107
839 EAR PAIN 107
840 RENAL CYST 107
841 RESPIRATORY ARREST 107
842 CHOLECYSTITIS ACUTE 106
843 FEELING HOT 106
844 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 106
845 PARAPARESIS 106
846 T-CELL LYMPHOMA 106
847 BONE MARROW TRANSPLANT 105
848 GASTROINTESTINAL PERFORATION 105
849 HYPOTONIA 105
850 RIGHT VENTRICULAR FAILURE 105
851 SENSORY LOSS 105
852 DIALYSIS 104
853 GASTRIC HAEMORRHAGE 104
854 THROAT TIGHTNESS 104
855 BLOOD TRIGLYCERIDES INCREASED 103
856 BRAIN HERNIATION 103
857 EYE PAIN 103
858 PERIPHERAL SENSORIMOTOR NEUROPATHY 103
859 PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED 103
860 PNEUMONIA PSEUDOMONAL 103
861 THERAPY INTERRUPTED 103
862 ABDOMINAL PAIN LOWER 102
863 ABDOMINAL TENDERNESS 102
864 ANGIOEDEMA 102
865 DEVICE RELATED THROMBOSIS 102
866 SMALL INTESTINAL PERFORATION 102
867 THROMBOPHLEBITIS 102
868 TOOTH INFECTION 102
869 EXTRAVASATION 101
870 HAEMATOLOGICAL INFECTION 101
871 LIMB DISCOMFORT 101
872 MENINGITIS ASEPTIC 101
873 MIGRAINE 101
874 MOTOR DYSFUNCTION 101
875 REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME 101
876 RIB FRACTURE 101
877 TOOTH ABSCESS 101
878 VACCINATION FAILURE 101
879 CYSTITIS BACTERIAL 100
880 HEMIPLEGIA 100
881 HYPERTHERMIA 100
882 CARDIOPULMONARY FAILURE 99
883 CEREBRAL ISCHAEMIA 99
884 LUNG OPACITY 99
885 THERAPEUTIC PRODUCT EFFECT DECREASED 99
886 ANAL ABSCESS 98
887 DERMATOMYOSITIS 98
888 PERFORMANCE STATUS DECREASED 98
889 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 98
890 ANGIOPATHY 97
891 BLOOD PRESSURE SYSTOLIC INCREASED 97
892 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 97
893 HYPOKINESIA 97
894 MYELOID LEUKAEMIA 97
895 RALES 97
896 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 96
897 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 96
898 INFLAMMATORY MARKER INCREASED 96
899 PLEURITIC PAIN 96
900 RHINITIS 96
901 BLADDER CANCER 95
902 CROHN^S DISEASE 95
903 DYSSTASIA 95
904 HEPATITIS FULMINANT 95
905 LYMPHOMA TRANSFORMATION 95
906 MICROANGIOPATHY 95
907 SPINAL COMPRESSION FRACTURE 95
908 TOXIC ENCEPHALOPATHY 95
909 URINARY TRACT INFECTION BACTERIAL 95
910 BLOOD COUNT ABNORMAL 94
911 CLOSTRIDIUM COLITIS 94
912 EATING DISORDER 94
913 HYPERLIPIDAEMIA 94
914 METASTATIC NEOPLASM 94
915 NEPHROLITHIASIS 94
916 OSTEOPENIA 94
917 PRIMARY AMYLOIDOSIS 94
918 CRYPTOCOCCOSIS 93
919 FACIAL PARESIS 93
920 FIBROSIS 93
921 GLOMERULONEPHRITIS 93
922 MOVEMENT DISORDER 93
923 MYELITIS 93
924 TRAUMATIC LUNG INJURY 93
925 VARICELLA 93
926 ANAEMIA HAEMOLYTIC AUTOIMMUNE 92
927 BRONCHOSPASM 92
928 CONGENITAL APLASIA 92
929 DIARRHOEA HAEMORRHAGIC 92
930 ECZEMA 92
931 EYELID PTOSIS 92
932 IMMUNE SYSTEM DISORDER 92
933 INJURY 92
934 LYMPHADENOPATHY MEDIASTINAL 92
935 PNEUMONIA PNEUMOCOCCAL 92
936 RENAL TUBULAR INJURY 92
937 SKIN NECROSIS 92
938 SLEEP APNOEA SYNDROME 92
939 BLOOD LACTIC ACID INCREASED 91
940 BLOOD STEM CELL TRANSPLANT FAILURE 91
941 CORONARY ARTERY DISEASE 91
942 FLANK PAIN 91
943 GINGIVITIS 91
944 GRAND MAL CONVULSION 91
945 MEDICATION ERROR 91
946 MENINGITIS TUBERCULOUS 91
947 NEPHROPATHY 91
948 SCEDOSPORIUM INFECTION 91
949 ACUTE LEUKAEMIA 90
950 CLOSTRIDIUM TEST POSITIVE 90
951 COMPUTERISED TOMOGRAM THORAX ABNORMAL 90
952 CONCOMITANT DISEASE AGGRAVATED 90
953 DIABETIC KETOACIDOSIS 90
954 GLIOMA 90
955 HEPATITIS CHOLESTATIC 90
956 HYPOTHERMIA 90
957 NOROVIRUS TEST POSITIVE 90
958 PROTHROMBIN TIME PROLONGED 90
959 RED CELL DISTRIBUTION WIDTH INCREASED 90
960 RESPIRATORY RATE INCREASED 90
961 SARCOIDOSIS 90
962 TOOTHACHE 90
963 TYPE 1 DIABETES MELLITUS 90
964 VAGINAL HAEMORRHAGE 90
965 DYSKINESIA 89
966 ENTEROVIRUS INFECTION 89
967 INJECTION SITE PAIN 89
968 SKIN HYPERPIGMENTATION 89
969 SPUTUM DISCOLOURED 89
970 SUICIDAL IDEATION 89
971 ENGRAFT FAILURE 88
972 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 88
973 FAILURE TO THRIVE 88
974 HYPOVOLAEMIC SHOCK 88
975 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 88
976 IRRITABILITY 88
977 LOWER GASTROINTESTINAL HAEMORRHAGE 88
978 STAPHYLOCOCCUS TEST POSITIVE 88
979 ACQUIRED HAEMOPHILIA 87
980 BLOOD CALCIUM DECREASED 87
981 ERYTHEMA MULTIFORME 87
982 GASTRIC CANCER 87
983 NASAL POLYPS 87
984 NEUROBLASTOMA 87
985 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 87
986 SARS-COV-2 TEST POSITIVE 87
987 VENA CAVA THROMBOSIS 87
988 ABORTION SPONTANEOUS 86
989 ACINETOBACTER INFECTION 86
990 BLOOD URIC ACID INCREASED 86
991 DEAFNESS NEUROSENSORY 86
992 HAEMOLYTIC URAEMIC SYNDROME 86
993 HEPATIC FIBROSIS 86
994 POST PROCEDURAL COMPLICATION 86
995 RESTLESSNESS 86
996 STRESS 86
997 ABORTION INDUCED 85
998 ENTEROCOLITIS INFECTIOUS 85
999 GASTROENTERITIS NOROVIRUS 85